These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32537065)

  • 1. Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa.
    Maphayi MR; Cassim N; Bello B; George JA
    Pan Afr Med J; 2020; 35():61. PubMed ID: 32537065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa.
    Heyns CF; Mathee S; Isaacs A; Kharwa A; De Beer PM; Pretorius MA
    BJU Int; 2003 Jun; 91(9):785-8. PubMed ID: 12780832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentation of prostate cancer in black South Africans.
    Tindall EA; Monare LR; Petersen DC; van Zyl S; Hardie RA; Segone AM; Venter PA; Bornman MS; Hayes VM
    Prostate; 2014 Jun; 74(8):880-91. PubMed ID: 24723425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship of Baseline Prostate Specific Antigen and Risk of Future Prostate Cancer and Its Variance by Race.
    Verges DP; Dani H; Sterling WA; Weedon J; Atallah W; Mehta K; Schreiber D; Weiss JP; Karanikolas NT
    J Natl Med Assoc; 2017 Spring; 109(1):49-54. PubMed ID: 28259216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson MA; Luo S; Chrusciel T; Yan Y; Grubb RL; Carson K; Scherrer JF
    Urol Oncol; 2014 Jan; 32(1):34.e9-18. PubMed ID: 23506962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.
    Howrey BT; Kuo YF; Lin YL; Goodwin JS
    J Gerontol A Biol Sci Med Sci; 2013 Jan; 68(1):56-61. PubMed ID: 22562961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis to describe trends in first-ever prostate-specific antigen (PSA) testing for primary healthcare facilities in the Gauteng Province, South Africa, between 2006 and 2016.
    Cassim N; Rebbeck TR; Glencross DK; George JA
    BMJ Open; 2022 Mar; 12(3):e050646. PubMed ID: 35314469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating racial differences in clinical and pathological features of prostate cancer in South African men.
    Dewar M; Kaestner L; Zikhali Q; Jehle K; Sinha S; Lazarus J
    S Afr J Surg; 2018 Jun; 56(2):54-58. PubMed ID: 30010267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Race is not a predictor of prostate cancer detection on repeat prostate biopsy.
    Carver BS; Bozeman CB; Simoneaux WJ; Venable DD; Kattan MW; Eastham JA
    J Urol; 2004 Nov; 172(5 Pt 1):1853-5. PubMed ID: 15540737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test.
    Abashidze N; Stecher C; Rosenkrantz AB; Duszak R; Hughes DR
    JAMA Netw Open; 2021 Nov; 4(11):e2132388. PubMed ID: 34748010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial variation in prostate specific antigen in a large cohort of men without prostate cancer.
    Eastham JA; Sartor O; Richey W; Moparty B; Sullivan J
    J La State Med Soc; 2001 Apr; 153(4):184-9. PubMed ID: 11394329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Foundation Screening Guidelines for Black Men in the United States.
    Garraway IP; Carlsson SV; Nyame YA; Vassy JL; Chilov M; Fleming M; Frencher SK; George DJ; Kibel AS; King SA; Kittles R; Mahal BA; Pettaway CA; Rebbeck T; Rose B; Vince R; Winn RA; Yamoah K; Oh WK
    NEJM Evid; 2024 May; 3(5):EVIDoa2300289. PubMed ID: 38815168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA) screening and follow-up investigations in Māori and non-Māori men in New Zealand.
    Obertová Z; Scott N; Brown C; Hodgson F; Stewart A; Holmes M; Lawrenson R
    BMC Fam Pract; 2014 Aug; 15():145. PubMed ID: 25154420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Earlier prostate-specific antigen testing in African American men--Clinical support for the recommendation.
    Saltzman AF; Luo S; Scherrer JF; Carson KD; Grubb RL; Hudson MA
    Urol Oncol; 2015 Jul; 33(7):330.e9-17. PubMed ID: 25937424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.
    Whittemore AS; Cirillo PM; Feldman D; Cohn BA
    J Urol; 2005 Sep; 174(3):872-6; discussion 876. PubMed ID: 16093978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
    Abdalla I; Ray P; Vaida F; Vijayakumar S
    Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
    Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
    Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
    Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
    J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.